Invicorp (Phentolamine Mesilate, Aviptadil)

Phentolamine mesilate blocks alpha‑adrenergic receptors on penile arterial smooth muscle, preventing vasoconstriction. This blockade leads to relaxation of the vessels, allowing more blood to enter the corpora cavernosa and supporting erection when sexual stimulation occurs.

The dose of Invicorp is determined by the prescribing physician based on the patient’s clinical condition, response, and safety considerations. No fixed regimen is provided publicly; the prescriber tailors the amount and frequency of intracavernous injection.

Safety data for Invicorp in pregnant or nursing women are lacking. Because the drug is intended for adult males with erectile dysfunction, it is generally not recommended for use during pregnancy or while breastfeeding.

To order Invicorp, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike oral PDE5 inhibitors that rely on systemic enzyme inhibition, Invicorp is administered directly into the penis and produces rapid vasodilation. It can be useful when oral agents are ineffective or contraindicated, but it requires professional injection and monitoring for local side effects.

Invicorp should be stored at 2‑8 °C in a refrigerator, protected from light and moisture. Do not freeze or shake the vial. Before use, allow the product to reach room temperature if required, and follow aseptic technique for intracavernous injection.

Invicorp is given as an intracavernous injection. A qualified healthcare professional injects the prescribed volume directly into the corpora cavernosa of the penis using a sterile needle and syringe, typically shortly before sexual activity.

The most serious adverse events include priapism (an erection lasting longer than four hours), severe hypotension that can cause dizziness or fainting, and rare allergic reactions such as anaphylaxis. Immediate medical attention is required if any of these occur.

Invicorp should not be used by individuals with known hypersensitivity to phentolamine mesilate, aviptadil, or any excipients, patients with severe coronary artery disease, uncontrolled hypertension, bleeding disorders, or those who have experienced priapism previously. Consultation with a physician is essential before starting therapy.